The usage of novel oral anticoagulants (NOACs) for stroke and systemic
The usage of novel oral anticoagulants (NOACs) for stroke and systemic embolism prevention in the setting of specifically non valvular atrial fibrillation has provided clinicians with an authentic treatment option to the original dose-adjusted, warfarin-based anticoagulation that’s geared to a therapeutic international normalized ratio selection of 2. systemic anticoagulants. Records: Reprinted with authorization Nagarakanti R, … [Read more…]